WINTON GROUP Ltd Buys 1,942 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

WINTON GROUP Ltd boosted its stake in Phibro Animal Health Co. (NASDAQ:PAHCGet Rating) by 12.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,388 shares of the company’s stock after acquiring an additional 1,942 shares during the period. WINTON GROUP Ltd’s holdings in Phibro Animal Health were worth $333,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. Teacher Retirement System of Texas purchased a new position in Phibro Animal Health during the first quarter valued at $545,000. Campbell & CO Investment Adviser LLC lifted its position in Phibro Animal Health by 183.2% during the first quarter. Campbell & CO Investment Adviser LLC now owns 29,246 shares of the company’s stock valued at $583,000 after buying an additional 18,920 shares during the period. Walleye Capital LLC lifted its position in Phibro Animal Health by 86.5% during the second quarter. Walleye Capital LLC now owns 64,134 shares of the company’s stock valued at $1,227,000 after buying an additional 29,749 shares during the period. State of Tennessee Treasury Department lifted its position in Phibro Animal Health by 17.9% during the first quarter. State of Tennessee Treasury Department now owns 7,703 shares of the company’s stock valued at $154,000 after buying an additional 1,167 shares during the period. Finally, Seizert Capital Partners LLC lifted its position in Phibro Animal Health by 55.6% during the second quarter. Seizert Capital Partners LLC now owns 29,677 shares of the company’s stock valued at $568,000 after buying an additional 10,607 shares during the period. Institutional investors own 50.97% of the company’s stock.

Analysts Set New Price Targets

PAHC has been the subject of several recent analyst reports. StockNews.com lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Friday, November 11th. Morgan Stanley lowered their price target on Phibro Animal Health from $21.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday, November 10th. Barclays lowered their price target on Phibro Animal Health from $22.00 to $17.00 and set an “underweight” rating for the company in a research report on Friday, September 16th. Finally, TheStreet lowered Phibro Animal Health from a “b-” rating to a “c+” rating in a research report on Wednesday, August 24th.

Phibro Animal Health Price Performance

Shares of NASDAQ:PAHC opened at $12.48 on Monday. Phibro Animal Health Co. has a fifty-two week low of $12.15 and a fifty-two week high of $22.74. The business has a 50-day simple moving average of $13.86 and a two-hundred day simple moving average of $16.85. The company has a debt-to-equity ratio of 1.72, a quick ratio of 1.68 and a current ratio of 3.30. The firm has a market cap of $505.49 million, a price-to-earnings ratio of 10.85 and a beta of 0.62.

Phibro Animal Health (NASDAQ:PAHCGet Rating) last issued its earnings results on Wednesday, August 24th. The company reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.04). Phibro Animal Health had a return on equity of 19.90% and a net margin of 4.85%. The business had revenue of $255.30 million during the quarter, compared to analysts’ expectations of $252.82 million. During the same period last year, the firm posted $0.32 EPS. On average, analysts expect that Phibro Animal Health Co. will post 1.25 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 21st. Shareholders of record on Wednesday, November 30th will be given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 3.85%. The ex-dividend date is Tuesday, November 29th. Phibro Animal Health’s dividend payout ratio (DPR) is 41.74%.

Phibro Animal Health Profile

(Get Rating)

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Featured Stories

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHCGet Rating).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.